The Manufacturers Life Insurance Company Has $15.35 Million Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

The Manufacturers Life Insurance Company cut its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 18.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 236,680 shares of the medical instruments supplier’s stock after selling 53,430 shares during the period. The Manufacturers Life Insurance Company owned 0.10% of DENTSPLY SIRONA worth $15,347,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Commonwealth Bank of Australia increased its holdings in shares of DENTSPLY SIRONA by 19.0% during the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares during the period. Acrospire Investment Management LLC acquired a new position in shares of DENTSPLY SIRONA during the second quarter valued at $113,000. Dupont Capital Management Corp acquired a new position in shares of DENTSPLY SIRONA during the second quarter valued at $116,000. Korea Investment CORP boosted its stake in DENTSPLY SIRONA by 139.9% during the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after buying an additional 1,251 shares in the last quarter. Finally, Sphera Funds Management LTD. bought a new position in DENTSPLY SIRONA during the second quarter valued at about $162,000. 93.89% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/28/dentsply-sirona-inc-xray-shares-sold-by-the-manufacturers-life-insurance-company.html.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) traded down 0.03% during midday trading on Friday, reaching $61.35. The company’s stock had a trading volume of 1,565,858 shares. The company’s market cap is $14.08 billion. The stock has a 50-day moving average of $58.85 and a 200 day moving average of $60.97. DENTSPLY SIRONA Inc. has a 12 month low of $52.54 and a 12 month high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm had revenue of $992.70 million for the quarter, compared to the consensus estimate of $1 billion. During the same quarter in the previous year, the business earned $0.76 EPS. The company’s revenue was down 2.9% compared to the same quarter last year. On average, analysts predict that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

Several brokerages recently weighed in on XRAY. Zacks Investment Research raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Friday, October 20th. Robert W. Baird set a $63.00 target price on DENTSPLY SIRONA and gave the company a “buy” rating in a research note on Thursday, October 19th. Stifel Nicolaus reiterated a “buy” rating on shares of DENTSPLY SIRONA in a research report on Thursday, October 19th. Morgan Stanley reiterated an “overweight” rating and issued a $69.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research report on Friday, October 6th. Finally, Cleveland Research lowered DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research report on Thursday, October 5th. Two analysts have rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company’s stock. DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus target price of $65.60.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply